Check out some of the most important premarket engines:
Verizon (VZ): Verizon reported quarterly earnings of $ 1.31 per share, 2 cents per share above estimates. Revenue also exceeded analysts ’forecasts. Verizon lost more wireless subscribers during the quarter than analysts had predicted.
Welbilt (WBT): Welbilt shares rose 14.8% in the pre-market after the professional food service equipment manufacturer agreed to be bought by rival Middleby (MIDD) in a securities transaction with an implicit value of $ 4.3 billion.
Anthem (ANTM): The health insurer earned $ 7.01 per share during its last quarter, surpassing estimates of 50 cents per share. Revenue did not reach Wall Street projections. Anthem also raised its outlook for the full year, amid growth in its various medical plans and higher revenue from pharmacy profit management. Shares rose 1.6% in premarket trading.
Halliburton (HAL) – Halliburton shares rose 2.4% in premarket shares after surpassing estimates by 2 cents per share, with a quarterly profit of 19 cents per share. Revenue was also above estimates, and the oil field services company said its U.S. business continues a healthy recovery.
Baker Hughes (BKR) – Oil services company shares rose 1.2% in pre-market shares after reporting quarterly earnings of 12 cents per share, one cent per share above estimates. Revenue essentially matched expectations. The profit fell by 40% compared to a year ago, affected by the severe winter weather.
Nasdaq (NDAQ): The stock trader earned $ 1.96 per share during the first quarter, 23 cents per share above estimates. Revenue also exceeded street forecasts. The results were driven by double-digit increases in equity and fixed income. Nasdaq also announced a 10% dividend increase.
Netflix (NFLX): Netflix fell 8.7% in premarket trading, even after surpassing estimates for the top and bottom lines of its last quarter. Investors are focusing on weaker subscriber growth numbers than expected for the video streaming giant.
CSX (CSX): CSX fell 2 cents per share below estimates, with a quarterly profit of 93 cents per share. The revenue of the railway operator exceeded forecasts. Pandemic-related outages and higher fuel costs affected CSX’s end result. CSX fell 1% in premarket trading.
Modern (MRNA) – Drug maker shares gained 1.1% in pre-market trade, following a new Covid-19 vaccine supply deal with Israel for 2022. Israel also gained an option to purchase vaccine doses designed to treat specific variants of the virus.
Norwegian Cruise Line (NCLH): Norwegian shares rose 2.4% in the pre-market after Goldman Sachs upgraded the cruise line operator to “buy” from “neutral”. Goldman cited several positive factors, including Norway’s capacity growth and low leverage compared to its peers.
Intuitive Surgical (ISRG): Intuitive Surgical earned $ 3.52 per share during its last quarter, well above the consensus-estimated $ 2.63 per share. Surgical device manufacturer’s revenue also exceeds forecasts, increasing the procedures used by the company’s devices as the Covid-19 pandemic is reduced. Shares gained 3.9% in premarket trading.
ASML (ASML): ASML gained 3.6% in premarketing shares after reporting better-than-expected earnings in the first quarter, as semiconductor manufacturing equipment supplier benefits from the overall increase in the demand for chips. ASML also raised its year-round outlook.
Tenet Healthcare (THC): Tenet reported a quarterly profit of $ 1.30 per share, compared to the 72-cent consensus estimate. The hospital operator’s income slightly exceeded expectations. Tenet said he was able to successfully tackle challenges related to both the pandemic and winter storms, and also gave an optimistic outlook. Tenet added 2.7% in premarket trade.
Interactive Brokers (IBKR): Interactive brokers earned 7 cents per share above estimates, with a quarterly profit of 98 cents per share. Revenue was well above estimates, with a 53% increase in trade commissions. Shares added 2.1% in premarket trading.
Edwards Lifesciences (EW): Edwards shares gained 3.8% in the premarket after surpassing estimates by 7 cents per share, with a quarterly profit of 54 cents per share. Revenue also exceeded consensus forecasts and the medical device company also raised its year-round forecast for a projected increase in demand for heart-related procedures.